These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor. Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505 [TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb. Naimushin YA; Mazurov AV Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313 [TBL] [Abstract][Full Text] [Related]
10. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation. Grainick HR; Williams SB; Coller BS J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249 [TBL] [Abstract][Full Text] [Related]
11. Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions. Wagner CT; Kroll MH; Chow TW; Hellums JD; Schafer AI Biorheology; 1996; 33(3):209-29. PubMed ID: 8935180 [TBL] [Abstract][Full Text] [Related]
12. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations. de Romeuf C; Hilbert L; Mazurier C Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349 [TBL] [Abstract][Full Text] [Related]
13. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148 [TBL] [Abstract][Full Text] [Related]
14. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. Miyake T; Nomura S; Komiyama Y; Miyazaki Y; Kagawa H; Masuda M; Takahashi H; Fujimura Y; Ikeda Y; Fukuhara S Thromb Haemost; 1997 Aug; 78(2):902-9. PubMed ID: 9268193 [TBL] [Abstract][Full Text] [Related]
15. Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease. Murata M; Fukuyama M; Satoh K; Fujimura Y; Yoshioka A; Takahashi H; Handa M; Kawai Y; Watanabe K; Ikeda Y J Clin Invest; 1993 Sep; 92(3):1555-8. PubMed ID: 8376606 [TBL] [Abstract][Full Text] [Related]
16. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Wu YP; Vink T; Schiphorst M; van Zanten GH; IJsseldijk MJ; de Groot PG; Sixma JJ Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1661-7. PubMed ID: 10845886 [TBL] [Abstract][Full Text] [Related]
17. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54. Naimushin YA; Mazurov AV Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942 [TBL] [Abstract][Full Text] [Related]
18. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor. Hoylaerts MF Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916 [TBL] [Abstract][Full Text] [Related]